Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_assertion evidence source_evidence_literature NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_assertion SIO_000772 9168435 NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_assertion wasDerivedFrom befree-20150227 NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_assertion wasGeneratedBy ECO_0000203 NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.